Guided Therapeutics, Inc.
GTHP
$0.0831
-$0.0059-6.63%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.15M | -2.17M | -3.02M | -3.49M | -4.91M |
| Total Depreciation and Amortization | 93.00K | 90.00K | 88.00K | 85.00K | 84.00K |
| Total Amortization of Deferred Charges | 105.00K | 115.00K | 130.00K | 130.00K | 129.00K |
| Total Other Non-Cash Items | -68.00K | 35.00K | 1.12M | 1.63M | 3.11M |
| Change in Net Operating Assets | 898.00K | 811.00K | 341.00K | -105.00K | -164.00K |
| Cash from Operations | -1.12M | -1.12M | -1.35M | -1.75M | -1.75M |
| Capital Expenditure | -- | -- | -- | -- | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -3.00K |
| Total Debt Issued | 387.00K | 200.00K | -- | -- | -- |
| Total Debt Repaid | -313.00K | -384.00K | -286.00K | -412.00K | -442.00K |
| Issuance of Common Stock | 541.00K | 241.00K | 241.00K | 436.00K | 228.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -29.00K | -17.00K | -- | -- | 0.00 |
| Cash from Financing | 586.00K | 40.00K | -45.00K | 24.00K | -214.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -537.00K | -1.08M | -1.39M | -1.72M | -1.97M |
